Mumbai-based Entod Pharmaceuticals has appointed Dr Anish Desai as its Scientific and Research Adviser. Dr Desai, a Clinical Pharmacologist with expertise in pharmaceuticals and nutraceuticals, brings over 30 years of distinguished experience spanning academia, research, and the healthcare industry.

Known for his strategic vision, innovative problem-solving skills, and entrepreneurial mindset, Dr Desai has been instrumental in driving sustainable growth and revenue generation for numerous organisations.

In his new role, Dr Desai will guide Entod’s research strategies, focussing on integrating progressive methodologies to develop novel therapies in ophthalmology, ENT, and dermatology. His appointment comes as Entod strengthens its commitment to leveraging advanced technologies for creating impactful healthcare solutions that address unmet patient needs. 

Entod’s current research pipeline is dedicated to addressing critical healthcare challenges, including myopia, digital eye strain, and glaucoma. Several of these treatments are anticipated to be industry-firsts in India, with some also expected to achieve global breakthroughs. Additionally, Entod is advancing indigenous formulations aimed at managing corneal scarring, keratitis, and neurotrophic keratitis, further cementing its role as a leader in healthcare innovation.